Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Medizinische Klinik (Munich, Germany : 1983)|June 22, 2005
[Successful treatment of a severe case of idiopathic pulmonary fibrosis with rapamycin]Lutz Buschhausen, Matthias Kamm, Wolfgang Arns, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 10, 2002
Meta-analysis of genotype-phenotype correlation in X-linked Alport syndrome: impact on clinical counsellingOliver Gross, Kai-Olaf Netzer, Romy Lambrecht, et al.
Medizinische Klinik (Munich, Germany : 1983)|June 22, 2005
[The Jo-1 Syndrome--immunological findings and clinical manifestations]Bettina Seiberlich, Nicolas Hunzelmann, Axel Roers, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 2008
Living donor kidney transplantation from relatives with mild urinary abnormalities in Alport syndrome: long-term risk, benefit and outcomeOliver Gross, Manfred Weber, Jochen W U Fries, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 16, 2003
Novel COL4A4 splice defect and in-frame deletion in a large consanguine family as a genetic link between benign familial haematuria and autosomal Alport syndromeOliver Gross, Kai-Olaf Netzer, Romy Lambrecht, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 15, 2003
Identification of a new tumor suppressor gene located at chromosome 8p21.3-22Stefan Seibold, Claudia Rudroff, Manfred Weber, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 15, 2003
A novel evaluation method for paraffinized human renal biopsies using quantitative analysis of microdissected glomeruli and VCAM-1 as marker of inflammatory mesangial cell activationJochen W U Fries, Tanja Roth, Hans-Peter Dienes, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 9, 2007
Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndromeMarie-Louise Koepke, Manfred Weber, Eckhard Schulze-Lohoff, et al.
Kidney International|July 15, 2005
Nephroprotection by antifibrotic and anti-inflammatory effects of the vasopeptidase inhibitor AVE7688Oliver Gross, Marie-Louise Koepke, Bogdan Beirowski, et al.
Pharmacoeconomics|June 10, 2006
Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients: modelling study from the hospital perspective in GermanyPeter K Schädlich, Michael Kentsch, Manfred Weber, et al.
Pageof 4